EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

Bakker, D.S. (Daphne S.), Ariens, L.F.M. (Lieneke F. M.), Giovannone, B. (Barbara), D.-J. Hijnen (Dirk-Jan), Delemarre, E.M. (Eveline M.), E.F. Knol (Edward Frank), Nierkens, S. (Stefan), M.S. de Bruin-Weller (M.), J.L. Thijs (Judith) and J. Drylewicz (Julia)

2020-07-10

Additional Metadata
Keywords	atopic dermatitis, biologics, biomarkers
Persistent URL	doi.org/10.1111/all.14492, hdl.handle.net/1765/129176
Journal	Allergy
Organisation	Department of Dermatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Bakker, D.S. (Daphne S.), Ariens, L.F.M. (Lieneke F. M.), Giovannone, B. (Barbara), Hijnen, D.-J., Delemarre, E.M. (Eveline M.), Knol, E. F., … Drylewicz, J. (2020). EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Allergy. doi:10.1111/all.14492

Publication